{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:34:51Z","timestamp":1779244491725,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T00:00:00Z","timestamp":1323993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028570","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T16:59:08Z","timestamp":1324054748000},"page":"e28570","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count &lt;200 Cells\/\u00b5L and Virologic Suppression: A Systematic Review"],"prefix":"10.1371","volume":"6","author":[{"given":"Cecilia T.","family":"Costiniuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,16]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"58","author":"JE Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against PCP in HIV-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.","volume":"340","author":"H Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"ref3","first-page":"179","article-title":"Discontinuation of prophylaxis against opportunistic infections in HIV-infected persons receiving potent combination antiretroviral therapy.","volume":"1","author":"H Furrer","year":"1999","journal-title":"AIDS Reviews"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"14","author":"V Soriano","year":"2000","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4269\/ajtmh.2006.74.738","article-title":"Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi.","volume":"74","author":"JE Gimnig","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1345\/aph.1G525","article-title":"Increased adverse reactions to antimicrobials and anticonvulsants in patients with HIV infection.","volume":"40","author":"D Lin","year":"2006","journal-title":"Ann Pharmacother"},{"key":"ref7","first-page":"154","article-title":"Predictive Value of HIV-1 viral load on risk of opportunistic infection.","volume":"30","author":"S Swindells","year":"2002","journal-title":"JAIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00002030-199906180-00006","article-title":"Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.","volume":"13","author":"P Williams","year":"1999","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00002030-200109280-00012","article-title":"Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents.","volume":"15","author":"JE Kaplan","year":"2001","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.297.21.2349","article-title":"Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slopes for progression to AIDS and death in untreated HIV-1 infection.","volume":"297","author":"JW Mellors","year":"2007","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002030-199902250-00006","article-title":"Prognostic value of plasma HIV RNA in the natural history of <italic>Pneumocystis carinii<\/italic> pneumonia, cytomegalovirus and Mycobacterium avium complex.","volume":"13","author":"RH Lyles","year":"1999","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/QAD.0b013e32826fb6fc","article-title":"<italic>Pneumocystis jiroveci<\/italic> pneumonia prophylaxis is not required with a CD4+ T cell count &lt;200 cells\/\u00b5\/L when viral replication is suppressed.","volume":"21","author":"GE D'Egidio","year":"2007","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ije\/30.4.864","article-title":"Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.","volume":"30","author":"Y Yazdanpanah","year":"2001","journal-title":"Int J Epi"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/655761","article-title":"Is it safe to discontinue primary <italic>Pneumocystis jiroveci<\/italic> pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count &lt;200 cells\/\u00b5L?","volume":"51","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-10-126","article-title":"Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.","volume":"10","author":"CY Cheng","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1086\/323198","article-title":"Discontinuation of <italic>Pneumocystis carinii<\/italic> prophylaxis in patients infected with human immunodeficiency virus: A meta-analysis and decision analysis.","volume":"33","author":"TA Trikalinos","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref17","article-title":"Discontinuing primary and secondary PCP prophylaxis in patients who have increased CD4 counts in response to antiretroviral therapy: preliminary results-ACTG 888 [abstract 243].","author":"SL Koletar","year":"2000"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against <italic>Pneumocystis carinii<\/italic> pneumonia in patients with HIV infection who have a response to antiretroviral therapy.","volume":"344","author":"B Ledergerber","year":"2001","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-132-3-200002010-00005","article-title":"Discontinuation of chemoprophylaxis against <italic>Pneumocystis carinii<\/italic> pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) investigators.","volume":"132","author":"BG Yangco","year":"2000","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-199909100-00007","article-title":"Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?","volume":"13","author":"O Kirk","year":"1999","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of <italic>Pneumocystis carinii<\/italic> pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.","volume":"353","author":"GJ Weverling","year":"1999","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(98)07204-3","article-title":"Discontinuation of prophylaxis for <italic>Pneumocystis carinii<\/italic> pneumomia in HIV-1 infected patients treated with highly active antiretroviral therapy.","volume":"353","author":"MM Schneider","year":"1999","journal-title":"Lancet"},{"key":"ref23","first-page":"89","article-title":"Withdrawal of <italic>Pneumocystis carinii<\/italic> pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment: study of 85 cases.","volume":"113","author":"E Garcia Vazquez","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/315471","article-title":"Discontinuation of primary prophylaxis for <italic>Pneumocystis carinii<\/italic> pneumonia and toxoplasmosis encephalitis in human immunodeficiency virus type 1-infected patients: the changes in opportunistic prophylaxis study.","volume":"181","author":"C Mussini","year":"2000","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200101183440301","article-title":"A randomized trial of the discontinuation of primary and secondary prophylaxis against <italic>Pneumocystis carinii<\/italic> pneumonia after highly active antiretroviral therapy in patients with HIV infection.","volume":"344","author":"JC Lopez Bernaldo","year":"2001","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/315734","article-title":"Risk for preventable opportunistic infections in persons with AIDS after antiretroviral thereapy increases CD4+ T lymphocyte counts above prophylaxis thresholds. The Adult\/Adolescent Spectrum of HIV Disease Project.","volume":"182","author":"MS Dworkin","year":"2000","journal-title":"J Infect Dis"},{"key":"ref27","article-title":"<italic>Pneumocystis carinii<\/italic> prophylaxis withdrawal in highly active antiretroviral therapy responsive patients [abstract I-206].","author":"JA Maradona","year":"1998"},{"key":"ref28","article-title":"Discontinue primary prophylaxis regimens in selected HIV-infected patients treated with HAART [abstract 31225].","author":"I Ravaux","year":"1998"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00126334-200102010-00007","article-title":"<italic>Pneumocystis carinii<\/italic> pneumonia recurrence in HIV patients on highly active antiretroviral therapy: Secondary prophylaxis.","volume":"26","author":"S Abgrall","year":"2001","journal-title":"J Acquir Imm Defic Synd"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/367659","article-title":"Discontinuation of secondary prophylaxis for <italic>Pneumocystis carinii<\/italic> Pneumonia in Human immunodeficiency Virus-infected patients: A randomized trial by the CIOP study group.","volume":"36","author":"C Mussini","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1097\/00002030-200410210-00009","article-title":"Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: Prospective multicentre study.","volume":"18","author":"C Zellweger","year":"2004","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of <italic>Pneumocystis carinii<\/italic> prophylaxis in patients with the acquired immunodeficiency syndrome.","volume":"327","author":"WD Hardy","year":"1992","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against <italic>Pneumocystis carinii<\/italic> pneumonia in patients with human immunodeficiency virus infection.","volume":"327","author":"MM Schneider","year":"1992","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/infdis\/171.6.1632","article-title":"Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against <italic>Pneumocystis carinii<\/italic> Pneumonia in patients with human immunodeficiency virus.","volume":"171","author":"MM Schneider","year":"1995","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three anti-pneumocystis agents in patients with advanced human immunodeficiency virus infection.","volume":"332","author":"SA Bozette","year":"1995","journal-title":"N Engl J Med"},{"key":"ref36","first-page":"2","article-title":"Pathogenesis of HIV infection: Total CD4+ T-cell pool, immune activation, and inflammation.","volume":"18","author":"HC Lane","year":"2010","journal-title":"Top HIV Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/498979","article-title":"Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.","volume":"193","author":"A Weinberg","year":"1996","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standarddose to a double dose.","volume":"23","author":"MO Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine.","volume":"139","author":"MJ Levine","year":"2001","journal-title":"J Pediatr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1016\/j.vaccine.2008.08.032","article-title":"Effectiveness of the 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998\u20132003.","volume":"26","author":"EH Teshale","year":"2008","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/598193","article-title":"Randomized double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.","volume":"48","author":"J Evison","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref42","first-page":"126","article-title":"Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms.","volume":"21","author":"A Justice","year":"1999","journal-title":"J Acquir Immun Def Synd"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of <italic>Pneumocystis carinii<\/italic> prophylactic regimens.","volume":"156","author":"JPA Ioannidis","year":"1996","journal-title":"Arch Intern Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T21:22:31Z","timestamp":1561065751000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028570"}},"subtitle":[],"editor":[{"given":"Aric","family":"Gregson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,16]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028570","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,16]]}}}